Effect of variable doses of antilymphocyte serum on T cell depletion and cardiac allograft survival.
Hylkema
M N
MN
Department of Histology & Cell Biology, University of Groningen, The Netherlands.
Pater
J M
JM
Klatter
F A
FA
van der Deen
M
M
van Asperen
R M
RM
Themmen
M
M
Raué
H P
HP
Groen
H
H
Nieuwenhuis
P
P
D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D001402:B-Lymphocytes / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D006649:Histocompatibility Antigens; D007165:Immunosuppression Therapy; D018655:Lymphocyte Count; D008212:Lymphocyte Depletion; D017710:Lymphocyte Transfusion; D051381:Rats; D011919:Rats, Inbred Strains; D013154:Spleen / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D013997:Time Factors; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D006649:Histocompatibility Antigens; C038353:histocompatibility antigens RT, rat